What is Celligent Diagnostics?
Celligent Diagnostics is a specialized provider of innovative pathology services, catering to the critical diagnostic needs of the medical community. The company's comprehensive service portfolio includes histology, women's health diagnostics, and ancillary testing, all meticulously designed to elevate patient care through the delivery of precise and timely results. Celligent Diagnostics streamlines the ordering process for ancillary testing via an intuitive web form, ensuring efficiency for both clients and referring healthcare facilities. Their core mission revolves around advancing healthcare outcomes by leveraging cutting-edge pathology solutions.
How much funding has Celligent Diagnostics raised?
Celligent Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Celligent Diagnostics?
The substantial capital infusion, particularly the recent strategic investment, positions Celligent Diagnostics for accelerated growth and market penetration. As a company operating within the large-scale late-stage funding environment, this financing is likely earmarked for scaling operational capacity, expanding service offerings, and potentially exploring new technological integrations within pathology. The strategic nature of the recent backing suggests a focus on enhancing competitive advantages and solidifying its market leadership in diagnostic services. Future developments may include broader geographic reach and deeper integration of AI or advanced analytics into their diagnostic workflows.
See full Celligent Diagnostics company page
